Sung-Hyun Kim, and Dong-Wook Kim. 2015. “Comment on ‘Efficacy and Safety of Radotinib in Chronic Phase Chronic Myeloid Leukemia Patients With Resistance or Intolerance to BCR-ABL1 Tyrosine Kinase inhibitors’”. Haematologica 100 (3). Pavia, Italy, e120-e121. https://doi.org/10.3324/haematol.2014.123232.